Effect of blood product medium supplements on the activity of cefotaxime and other cephalosporins against Enterococcus faecalis
- 30 April 1989
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (2), 149-156
- https://doi.org/10.1016/0732-8893(89)90006-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Influence of the developmental state of valvular lesions on the antimicrobial activity of cefotaxime in experimental enterococcal infectionsAntimicrobial Agents and Chemotherapy, 1985
- Enterococcal superinfection and colonization with aztreonam therapyAntimicrobial Agents and Chemotherapy, 1984
- Empiric Therapy With Moxalactam Alone in Patients With BacteremiaMayo Clinic Proceedings, 1984
- Protein Dynamics during Refeeding of Protein-Depleted Rats: Effects of Increasing Amino Acid Intake by TPN or Enteral Continuous FeedingJournal of Nutrition, 1984
- Binding of fibronectin to the surface of group A, C, and G streptococci isolated from human infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1982
- Cefotaxime and Cephalosporins: Adverse Reactions in PerspectiveClinical Infectious Diseases, 1982
- The New Beta-Lactamase-Stable CephalosporinsAnnals of Internal Medicine, 1982
- Resistance to beta-lactam antibiotics in Streptococcus faeciumAntimicrobial Agents and Chemotherapy, 1982
- Therapy for Experimental Intraabdominal Sepsis: Comparison of Four Cephalosporins with Clindamycin Plus GentamicinThe Journal of Infectious Diseases, 1977
- A Film Detection Method for Tritium‐Labelled Proteins and Nucleic Acids in Polyacrylamide GelsEuropean Journal of Biochemistry, 1974